Man Boob vs Gyno: Key Differences Explained

Man boob vs gyno is a common source of confusion, yet the two conditions have distinct causes and require different treatments. 'Man boobs', medically termed pseudogynaecomastia, result from excess chest fat, while gynaecomastia involves the growth of actual glandular breast tissue driven by a hormonal imbalance. Telling them apart matters because one may respond to lifestyle changes, while the other often requires clinical investigation and specialist management. This article explains the key differences, how to identify which condition you may have, what causes each, when to seek medical advice, and what treatment options are available on the NHS and privately.

What is the difference between man boobs and gynaecomastia?

Gynaecomastia is the benign enlargement of glandular breast tissue caused by a hormonal imbalance, while pseudogynaecomastia is chest fat accumulation without glandular involvement, typically linked to excess body weight.

Gynaecomastia and pseudogynaecomastia (commonly called 'man boobs') are two distinct conditions that look similar but have different underlying causes and require different approaches to management. Gynaecomastia is the benign enlargement of glandular breast tissue in males, driven by a hormonal imbalance between oestrogen and testosterone.^[1][2] Pseudogynaecomastia, by contrast, is the accumulation of fatty tissue in the chest area without any increase in glandular tissue, and is closely linked to excess body weight.

The distinction matters clinically because the two conditions respond to very different interventions. Gynaecomastia involves actual breast gland development and will not resolve with weight loss alone, whereas pseudogynaecomastia typically improves when overall body fat is reduced through diet and exercise. It is worth noting, however, that excess adipose tissue can itself raise circulating oestrogen levels through a process called peripheral aromatisation, meaning that significant weight gain can sometimes contribute to true gynaecomastia alongside chest fat accumulation.^[2][4] Both conditions are common and, in most cases, benign, but they can cause significant psychological distress, including reduced self-confidence and anxiety about appearance.

Some men have a combination of both: enlarged glandular tissue alongside excess chest fat. In these cases, accurate diagnosis is particularly important before any treatment is considered. Understanding which condition is present is the essential first step, and this is best determined through a clinical assessment rather than self-diagnosis alone. The NHS and NICE Clinical Knowledge Summary (CKS) on gynaecomastia provide further patient-facing information on both conditions.

How can you tell which one you have?

A firm, rubbery disc beneath the nipple suggests gynaecomastia, whereas uniformly soft chest tissue with no central mass is more consistent with pseudogynaecomastia; a GP assessment is needed to confirm the diagnosis.

The most reliable way to distinguish gynaecomastia from pseudogynaecomastia is a physical examination by a clinician, but there are some features that can help guide initial self-assessment. In gynaecomastia, there is typically a firm or rubbery disc of tissue directly beneath the nipple or areola, which may feel tender or sensitive to touch. This glandular tissue is distinct from the surrounding area and does not move freely in the way that fatty tissue does.

In pseudogynaecomastia, the chest enlargement tends to feel soft and uniform, similar in consistency to fat elsewhere on the body, such as the abdomen or flanks. There is no firm central mass beneath the nipple, and the tissue is generally not tender. Men with pseudogynaecomastia often notice that their chest size fluctuates with changes in body weight.

A useful self-check involves lying flat on your back and gently pressing the fingertips toward the nipple from either side. If a firm, disc-like structure is felt beneath the nipple, this is more consistent with glandular tissue and therefore gynaecomastia. If the tissue feels uniformly soft with no central firmness, pseudogynaecomastia is more likely. However, self-examination has clear limitations and cannot rule out other causes, including male breast cancer. It should never delay a GP assessment where there is any doubt.

A GP can arrange further investigations, including blood tests and, where appropriate, imaging. In a breast clinic setting, assessment typically follows a 'triple assessment' approach: clinical examination, imaging (ultrasound and, depending on age and presentation, mammography), and needle biopsy if indicated.^[9][10] This is the standard UK pathway for any breast presentation where the diagnosis is uncertain. Do not delay seeking a clinical opinion if you are uncertain or concerned.

What causes gynaecomastia and pseudogynaecomastia in men?

Gynaecomastia is caused by relative oestrogen excess due to hormonal shifts, medical conditions, or medications, while pseudogynaecomastia is caused primarily by excess body fat accumulating in the chest.

Gynaecomastia is caused by an imbalance between oestrogen and testosterone, resulting in relative oestrogen excess that stimulates glandular breast tissue growth. This hormonal shift can occur at several life stages: in newborns (due to maternal oestrogens), during puberty (when hormone levels fluctuate), and in older men (as testosterone levels naturally decline with age). In many adolescent boys, pubertal gynaecomastia resolves spontaneously within one to two years without treatment.^[1][2]

A range of medical conditions and medications can also trigger gynaecomastia. These include:

• Hypogonadism (reduced testosterone production), including Klinefelter syndrome

• Hyperthyroidism and other endocrine disorders

• Hyperprolactinaemia, including that caused by pituitary tumours

• Liver disease, including cirrhosis, which affects oestrogen metabolism

• Chronic kidney disease

• Malnutrition and re-feeding states

• Testicular tumours, which may secrete oestrogen or human chorionic gonadotrophin (hCG)

• Medications, including spironolactone, cimetidine, digoxin, finasteride, dutasteride, bicalutamide and other anti-androgens, GnRH analogues, some antipsychotics, anabolic steroids, and certain antiretrovirals (including efavirenz)

• Alcohol and some opioids, which are recognised contributing factors

• Anabolic steroid use, a recognised cause particularly in younger men

• Cannabis use, which has been reported in association with gynaecomastia, though the evidence is limited and not conclusive^[18][19]

Pseudogynaecomastia, by contrast, is caused primarily by excess body fat. As adipose tissue accumulates across the body, including the chest, the appearance of enlarged breasts develops without any hormonal or glandular component. Obesity also raises circulating oestrogen levels because adipose tissue converts androgens to oestrogens via peripheral aromatisation, which means that significant weight gain can sometimes contribute to true gynaecomastia as well.^[2][4] Identifying the underlying cause is important because treating a reversible trigger, such as stopping a causative medication or managing an endocrine condition, may resolve the gynaecomastia without further intervention. The NICE CKS on gynaecomastia and NHS patient information provide further detail on recognised causes.

When should you see a GP about chest swelling or breast tissue?

See a GP promptly if you notice a new breast lump, nipple discharge, skin changes, or rapidly increasing swelling, as male breast cancer, though rare, must be excluded.

You should see a GP if you notice any new or unexplained breast tissue enlargement, particularly if it is accompanied by tenderness, nipple discharge, skin changes, or a hard or irregular lump. While gynaecomastia is almost always benign, male breast cancer, though rare, does occur, and any persistent or asymmetric breast lump warrants prompt clinical assessment.

NICE guidance on suspected cancer (NG12) sets out criteria for urgent referral in people with breast symptoms. For men, an unexplained breast lump should prompt consideration of an urgent referral, particularly where there are associated features such as nipple changes or axillary lymphadenopathy. Your GP will apply these criteria based on your age, symptoms, and examination findings. If you are concerned, ask your GP whether an urgent referral is appropriate.

You should also see a GP if:

• Breast enlargement has appeared suddenly or is rapidly increasing in size

• You are experiencing pain or significant tenderness in the breast tissue

• You have noticed nipple discharge of any kind

• The swelling is affecting only one side

• You are taking a medication that may be contributing and wish to discuss alternatives

• The condition is causing significant psychological distress

For adolescent boys, a GP review is appropriate if gynaecomastia persists beyond two years, is causing distress, or is associated with other signs of hormonal abnormality.^[1][4]

A GP will typically arrange blood tests to assess hormone levels (including testosterone, luteinising hormone, follicle-stimulating hormone, oestradiol, and prolactin), liver and kidney function, and thyroid function.^[1][4] Where a testicular tumour is suspected, tumour markers including beta-hCG and, where indicated, alpha-fetoprotein (AFP) may also be measured, alongside a testicular ultrasound.^[4][7] Suspicious presentations may be referred to a breast clinic for triple assessment (clinical examination, imaging, and biopsy if indicated).

Contact your GP in the first instance. If you develop symptoms of a separate acute emergency, such as severe chest pain, sudden breathlessness, or collapse, call 999 or attend A&E immediately.

What treatment options are available on the NHS and privately?

Pseudogynaecomastia is managed with diet and exercise; gynaecomastia may require treating the underlying cause, watchful waiting, off-label medication, or surgery, with NHS funding subject to local ICB criteria.

Treatment for gynaecomastia and pseudogynaecomastia depends on the underlying cause, the severity of symptoms, and how long the condition has been present. For pseudogynaecomastia, the primary approach is lifestyle modification, specifically a sustained reduction in body fat through a balanced diet and regular physical activity. There is no medication licensed specifically for pseudogynaecomastia, and surgical intervention is generally not offered on the NHS for this indication alone.

For true gynaecomastia, management options include:

• Treating the underlying cause: Stopping a causative medication or managing an endocrine disorder may lead to gradual resolution, particularly if the condition is recent.

• Watchful waiting: In pubertal gynaecomastia, spontaneous resolution is common and is the recommended approach in most cases.

• Pharmacological treatment: Tamoxifen (an anti-oestrogen) and aromatase inhibitors such as anastrozole have been used off-label in some cases, particularly where the condition is painful or persistent. These are not MHRA-authorised specifically for gynaecomastia, and their use is guided by specialist assessment. Medical therapy is generally considered more effective when started early, within approximately the first six to twelve months of onset, before fibrotic changes become established.^[2][4] Tamoxifen carries a risk of venous thromboembolism and other side effects; anastrozole has a limited evidence base in this context.^[15][16] Both should be initiated and monitored by a specialist rather than used without supervision.

• Surgery: Surgical reduction (mastectomy or liposuction, or a combination) is the most definitive treatment for established gynaecomastia. NHS funding for this procedure is subject to local Integrated Care Board (ICB) commissioning decisions, which vary across England, and is generally reserved for cases causing significant functional or psychological impact where conservative measures have not been sufficient. A GP or specialist can advise on local criteria and referral pathways. Privately, surgical correction is widely available and is typically performed by a plastic or breast surgeon.

For men exploring weight-management options that may indirectly address pseudogynaecomastia, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, alongside other clinical pathways a GP may recommend. Any weight-management medicine would only be prescribed where clinically appropriate following a consultation. Any treatment plan should be guided by a qualified clinician following a thorough assessment. Suspected adverse effects from any medication should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Scientific References

1. Gynaecomastia.
2. Gynecomastia: pathomechanisms and treatment strategies.
3. The Impact and Management of Gynaecomastia in Klinefelter Syndrome.
4. EAA clinical practice guidelines—gynecomastia evaluation and management.
5. An oestrogen-producing seminoma responsible for gynaecomastia.
6. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis.
7. Rare β-human chorionic gonadotrophin-secreting urothelial carcinoma initially presenting as gynecomastia.
8. Suspected cancer: recognition and referral (NG12).
9. Clinical guidance for breast cancer screening assessment (triple assessment).
10. Tests and next steps for breast cancer in women.
11. MHRA authorises anastrozole to prevent breast cancer (post-menopausal women).
12. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.
13. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
14. Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer.
15. Tamoxifen and risk of idiopathic venous thromboembolism.
16. Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism.
17. Breast reduction (male).
18. Gynecomastia and cannabis smoking. A nonassociation.
19. Drug-induced gynecomastia.

Frequently Asked Questions